GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Trimmed by River Global Investors LLP

River Global Investors LLP lessened its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.1% in the fourth quarter, HoldingsChannel reports. The fund owned 17,954 shares of the company’s stock after selling 1,593 shares during the period. River Global Investors LLP’s holdings in GE HealthCare Technologies were worth $1,388,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Todd Asset Management LLC acquired a new stake in GE HealthCare Technologies in the fourth quarter worth about $10,145,000. Knuff & Co LLC lifted its stake in shares of GE HealthCare Technologies by 50.6% in the 4th quarter. Knuff & Co LLC now owns 9,112 shares of the company’s stock worth $705,000 after acquiring an additional 3,061 shares during the period. Merit Financial Group LLC lifted its stake in shares of GE HealthCare Technologies by 11.0% in the 4th quarter. Merit Financial Group LLC now owns 7,262 shares of the company’s stock worth $561,000 after acquiring an additional 719 shares during the period. 9258 Wealth Management LLC boosted its stake in GE HealthCare Technologies by 5.7% during the 4th quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock valued at $253,000 after purchasing an additional 176 shares in the last quarter. Finally, Amalgamated Bank increased its position in shares of GE HealthCare Technologies by 2.1% during the 4th quarter. Amalgamated Bank now owns 103,958 shares of the company’s stock valued at $8,038,000 after purchasing an additional 2,111 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 2.1 %

Shares of GEHC stock traded up $1.64 during trading hours on Friday, reaching $79.47. 2,722,865 shares of the stock traded hands, compared to its average volume of 3,070,492. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The business has a fifty day moving average price of $88.25 and a 200 day moving average price of $79.07. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. The firm has a market capitalization of $36.27 billion, a PE ratio of 23.24, a PEG ratio of 2.86 and a beta of 1.26.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.90. GE HealthCare Technologies had a net margin of 8.05% and a return on equity of 25.32%. The business had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same quarter in the previous year, the business earned $0.85 earnings per share. The firm’s revenue was down 1.2% compared to the same quarter last year. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a dividend of $0.03 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

Analysts Set New Price Targets

GEHC has been the topic of a number of research analyst reports. Evercore ISI lifted their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. HSBC assumed coverage on shares of GE HealthCare Technologies in a report on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price on the stock. UBS Group upgraded shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, April 3rd. Finally, Morgan Stanley boosted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $95.00.

Insider Activity

In other news, insider Frank R. Jimenez bought 1,315 shares of the company’s stock in a transaction on Wednesday, May 1st. The shares were bought at an average cost of $76.52 per share, with a total value of $100,623.80. Following the transaction, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.27% of the stock is owned by company insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.